Efficacy, safety, and tolerability of once‐daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7‐day, crossover study

Abediterol is a once‐daily, long‐acting β (2)‐adrenergic agonist in development for the treatment of asthma and chronic obstructive pulmonary disease. We assessed the efficacy, safety, and tolerability of three dose levels of abediterol, given once daily for 7 days in patients with stable, persisten...

Descripción completa

Detalles Bibliográficos
Autores principales: Beier, Jutta, Fuhr, Rainard, Seoane, Beatriz, Massana, Eric, de Miquel, Gonzalo, Pujol, Helena, Ruiz, Sandrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625160/
https://www.ncbi.nlm.nih.gov/pubmed/28971615
http://dx.doi.org/10.1002/prp2.356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625160/
https://www.ncbi.nlm.nih.gov/pubmed/28971615
http://dx.doi.org/10.1002/prp2.356

Ejemplares similares